Sumitomo Seika Chemicals Company, Limited.
(Correction) Formulation of the ‘Long-term Vision Toward 2045’ and the ‘Outline of the New Medium-term Management Plan (2026–2030)’
Amendments to the outline of the new medium-term management plan and the management targets for 2030 have been disclosed. The revised figures include: net sales of 200 billion yen, operating income of 17.5 billion yen, net income of 12.4 billion yen, ROE 10.0%, ROIC 8.5%, and a yen to yuan rate of 21.25. The organic growth premise remains unchanged.
Key Figures
- Net sales: 2,000 億円
- Operating income: 175 億円
- Net income: 124 億円
AI要約
Overview of the correction
We announce that there has been a correction in the description of the long-term vision and the outline of the new medium-term management plan published today. The figures for the 2030 management targets have been amended, with major indicators shown on a basis of sales against fiscal year 2025. Post-correction indicators include net sales of 200 billion yen, operating income of 17.5 billion yen, net income of 12.4 billion yen, ROE 10.0%, ROIC 8.5%, and the yen per yuan assumption of 21.25. The description of organic growth remains intact.
Impact going forward and disclosure context
The correction is intended to improve the accuracy of the disclosure and does not imply a comprehensive change to the earnings outlook itself. It aims to enhance transparency in the process of formulating the long-term vision and the medium-term plan and to strengthen information provision to investors. Further progress and any additional correction information may be disclosed, so ongoing attention is required.
Sumitomo Chemical Co., Ltd.
Company overview · Stock price · Financial data · All IR
